Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Endocrine

• Publication date

  2018-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12020-018-1534-3PMID 29411306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study

  2017cited by this paper
• Relaxin attenuates aristolochic acid induced human tubular epithelial cell apoptosis in vitro by activation of the PI3K/Akt signaling pathway

  2017cited by this paper
• Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.

  2017cited by this paper
• AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System

  2017cited by this paper
• Relaxin confers cytotrophoblast protection from hypoxia-reoxygenation injury through the phosphatidylinositol 3-kinase-Akt/protein kinase B cell survival pathway.

  2017cited by this paper
• Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence

  2017cited by this paper
• Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy

  2017cited by this paper
• Serelaxin in clinical development: past, present and future

  2017cited by this paper
• Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

  2017cited by this paper
• Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.

  2017cited by this paper
• Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.

  2016cited by this paper
• Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)

  2016cited by this paper
• Relaxin-2 improves diastolic function of pressure-overloaded rats via phospholamban by activating Akt.

  2016cited by this paper
• Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta.

  2016cited by this paper
• Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.

  2016cited by this paper
• Rab GAPs AS160 and Tbc1d1 play nonredundant roles in the regulation of glucose and energy homeostasis in mice.

  2016cited by this paper
• Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice.

  2016cited by this paper
• Relaxin in paraventricular nucleus contributes to sympathetic overdrive and hypertension via PI3K-Akt pathway.

  2016cited by this paper
• Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch‐1 pathway

  2015cited by this paper
• Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.

  2015cited by this paper
• Sex-specific effects of relaxin-3 on food intake and brain expression of corticotropin-releasing factor in rats.

  2015cited by this paper
• Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.

  2015cited by this paper
• H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes.

  2015cited by this paper
• Protection of cultured human hepatocytes from hydrogen peroxide‑induced apoptosis by relaxin‑3.

  2015cited by this paper
• Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.

  2015cited by this paper
• Diverse Regulation of Cardiac Expression of Relaxin Receptor by α1- and β1-Adrenoceptors

  2014cited by this paper
• Regulation of expression of relaxin-3 and its receptor RXFP3 in the brain of diet-induced obese rats.

  2014cited by this paper
• Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation

  2014cited by this paper
• The expression of relaxin-3 in adipose tissue and its effects on adipogenesis.

  2014cited by this paper
• 5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.

  2014cited by this paper
• Relaxin Activates Peroxisome Proliferator-activated Receptor γ (PPARγ) through a Pathway Involving PPARγ Coactivator 1α (PGC1α)*

  2014cited by this paper
• The plasma levels of relaxin-2 and relaxin-3 in patients with diabetes.

  2013cited by this paper
• Relaxin-3 is associated with metabolic syndrome and its component traits in women.

  2013cited by this paper
• Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

  2013cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts

  2013cited by this paper
• Relaxin family peptides and their receptors.

  2013influential reference
• Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling

  2013cited by this paper
• Relaxin Treatment Reverses Insulin Resistance in Mice Fed a High-Fat Diet

  2013cited by this paper
• Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production

  2013cited by this paper
• Relaxin, insulin and diabetes: an intriguing connection.

  2012cited by this paper
• Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration

  2012cited by this paper
• Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling.

  2012cited by this paper
• Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells[S]

  2011cited by this paper
• Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.

  2011cited by this paper
• Myocardial AKT: the omnipresent nexus.

  2011influential reference
• Relaxin: Review of Biology and Potential Role in Treating Heart Failure

  2010cited by this paper
• Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes.

  2010cited by this paper
• Central and peripheral administration of human relaxin‐2 to adult male rats inhibits food intake

  2010cited by this paper
• Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures.

  2009cited by this paper
• Prominent Role of Relaxin in Improving Postinfarction Heart Remodeling

  2009cited by this paper
• Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus.

  2008cited by this paper
• Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport.

  2007cited by this paper
• Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes.

  2007influential reference
• AMP-activated protein kinase and the regulation of glucose transport.

  2006cited by this paper
• Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle

  2006cited by this paper
• Human Recombinant Relaxin Reduces Heart Injury and Improves Ventricular Performance in a Swine Model of Acute Myocardial Infarction

  2005cited by this paper
• Adiponectin is synthesized and secreted by human and murine cardiomyocytes

  2005cited by this paper
• Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model

  2005cited by this paper
• Relaxin Favors the Morphofunctional Integration between Skeletal Myoblasts and Adult Cardiomyocytes in Coculture

  2005cited by this paper
• Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.

  2004cited by this paper
• Doxazosin Induces Apoptosis in Cardiomyocytes Cultured In Vitro by a Mechanism That Is Independent of &agr;1-Adrenergic Blockade

  2003cited by this paper
• The pregnancy hormone relaxin is a player in human heart failure

  2001cited by this paper
• Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.

  1999cited by this paper
• Cellular and Molecular Life Sciences REVIEW Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes

  year unknowncited by this paper

• Nonylphenol Exposure and Cardiovascular Toxicity: Mechanistic Insights and Integrated Risk Assessment from Experimental Models.

  2025cites this paper
• Investigating the association of previously identified genome-wide significant loci (rs10739076 and rs1784692) with PCOS susceptibility and its related traits in Indian women.

  2024cites this paper
• Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue.

  2024cites this paper
• Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes.

  2024cites this paper
• Serelaxin Protects H9c2 Cardiac Myoblasts against Hypoxia and Reoxygenation-Induced Damage through Activation of AMP Kinase/Sirtuin1: Further Insight into the Molecular Mechanisms of the Cardioprotection of This Hormone

  2024cites this paper
• AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration

  2023cites this paper
• Relaxin as a biological marker and therapeutic target in heart failure

  2023cites this paper
• Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases

  2022cites this paper
• Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension.

  2022cites this paper
• Low-dose arsenic trioxide enhances membrane-GLUT1 expression and glucose uptake via AKT activation to support L-02 cell aberrant proliferation.

  2022cites this paper
• Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

  2022cites this paper
• Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction

  2021cites this paper
• Relaxin has beneficial effects on liver lipidome and metabolic enzymes

  2021cites this paper
• Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target.

  2020cites this paper
• Pharmacological effects of natural Ganoderma and its extracts on neurological diseases: A comprehensive review.

  2019cites this paper
• Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.

  2019cites this paper
• Understanding relaxin signalling at the cellular level.

  2019cites this paper